Opioid Policy Change
| 3 min read
Daniel J. Loepp is President and Chief Executive Officer of Blue Cross Blue Shield of Michigan. Mr. Loepp has directed sweeping initiatives and innovations that have led to a historic transformation of BCBSM and health care in Michigan. He played a major role in modernizing the state’s health care delivery system in a process that led to enactment of new laws that transformed BCBSM to become a nonprofit mutual insurance company in January 2014. Mr. Loepp has led BCBSM initiatives to improve health care quality and slow cost increases, saving nearly $1.5 billion through several programs that have garnered national attention and served as models implemented across the country. Under his leadership, Blue Cross Blue Shield of Michigan is helping to revitalize and strengthen Detroit, Grand Rapids and Lansing. In 2011 and 2012, Blue Cross moved 3,000 BCBSM employees into downtown Detroit and the company is one of the largest employers in the city’s Central Business District. In Lansing, BCBSM subsidiary AF Group transformed a long abandoned power plant into a national headquarters. Mr. Loepp has stood by a commitment that BCBSM should be a driving force for good in Michigan’s core cities. It is reflected in BCBSM’s workforce diversity and inclusion efforts, supplier partnerships and community initiatives. In his tenure, BCBSM has been named Corporation of the Year in Finance and Insurance Services nine times by the Michigan Minority Supplier Development Council. The company has also been named one of America’s Top Organizations for Multi-Cultural Business Opportunities by DiversityBusiness.com and ranked five consecutive years as one of the top 10 Regional Companies for diversity by DiversityInc magazine, including being ranked No. 1 for consecutive years in 2015 and 2016. Mr. Loepp was honored as a 2016 recipient of the Edward N. McNamara Goodfellow of the Year Award. He was selected as Michiganian of the Year by The Detroit News in 2013. Mr. Loepp joined Blue Cross in 2000. In 2011, 2012 and 2013, he served as board chair of the Blue Cross and Blue Shield Association (BCBSA), an organization that includes all 36 Blue Cross plans and provides health coverage to more than 106 million Americans.
- Working directly with doctors to coordinate care to reduce opioid abuse and overdose from prescriptions for controlled substances from multiple doctors without their shared knowledge of prescriptions from others.
- Creation of the Opioids Provider Toolkit, which provides physician organizations links to best practices and resources, tips to safely manage pain, and information on available data and resources on opioid use.
- Development of awareness programs about deadly drug interactions from certain regimens with no legitimate medical rationale.
- Coordination of drug usage reviews and research alert physicians before patients take a combination of opioids and other medications that can lead to fatal overdose. After six months of working with doctors, we’ve seen a nearly 51 percent reduction in Blue Cross members taking both opioid and BZD drugs.
- Limiting opioid prescriptions to a 30-day supply, and restricting short-acting opioids to five days on initial prescriptions.